Laser Photocoagulation Combined with Intravitreal Triamcinolone Acetonide Injection in Proliferative Diabetic Retinopathy with Macular Edema
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Abstract
Purpose: To evaluate therapeutic effects and usefulness of a combination treatment of intravitreal injection of triamcinolone acetonide (IVTA) and panretinal photocoagulation (PRP) in patients with clinically significant macular edema secondary to proliferative diabetic retinopathy (PDR). Methods: Visual acuity test, fundoscopy, fluorescein angiography, and optical coherence tomography (OCT) were taken in 20 patients (20 eyes) of macular edema and PDR. A combination of intravitreal injection of triamcinolone acetonide and PRP was performed in 10 patients (10 eyes) and a combination of focal or grid laser photocoaqulation and PRP in the remaining 10 eyes. The postoperative outcomes were compared between the two combination treatments by best corrected visual acuity (BCVA), tonometry, fluorescein angiography, and OCT at 2 weeks, 1, 2, and 3 months. Results: Average BCVA (log MAR) significantly improved from preoperative 0.56±0.20 to 0.43±0.08 at 1 month (P=0.042) and it was maintained until 3 months after a combination of IVTA and PRP in 10 eyes (P=0.007). The thickness of fovea decreased from average 433.3±114.9 μm to average 279.5±34.1 μm at 2 weeks after combined treatment of IVTA and PRP (P=0.005), which was significantly maintained until 3 months, but there was a transient visual disturbance and no significant difference in thickness of the fovea before and after treatment in the groups with PRP and focal or grid laser photocoagulation. Conclusions: A combination of IVTA and PRP might be an effective treatment modality in the treatment of macular edema and PDR and prevent the subsequent PRP-induced macular edema result in visual dysfunction. In combination with PRP, IVTA might be more effective than focal or grid laser photocoagulation and PRP for reducing diabetic macular edema and preventing aggravation of macular edema without transient visual disturbance in patients requiring immediate PRP.
참고문헌 (29)
- Aiello LM, "Perspectives on diabetic retinopathy", 136, pp.122~135 (2003)
- Akduman L, "Laser photocoagulation of diabetic macular edema", 28, pp.387~408 (1997)
- Early Treatment Diabetic Retinopathy Study Research Group, "Photocoagulation for diabetic macular edema.Early Treatment Diabetic Retinopathy Study report number 1", 103, pp.1796~806 (1985)
- Early Treatment Diabetic Retinopathy Study Research Group, "Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema.Early Treatment Diabetic Retinopathy Study report number 2", 94, pp.761~74 (1987)
- Ferris FL, "Macular edema in diabetic retinopathy study patients.Diabetic Retinopathy Study Group report number 12", 94, pp.754~60 (1987)
- Kleiner RC, "Transient severe visual loss after panretinal photocoagulation", 106, pp.298~306 (1988)
- Meyers SM, "Macular edema after scatter laser photocoagulation for proliferative diabetic retinopathy", 90, pp.210~6 (1980)
- Shimura M, "Quantifying alterations of macular thickness before and after pan-retinal photocoagulation in patients with severe diabetic retinopathy and good vision", 110, pp.2386~2394 (2003)
- Shimura M, "Visual Dysfunction After Panretinal Photocoagulation in Patients With Severe Diabetic Retinopathy and Good Vision", 140, pp.8~15 (2005)
- Jonas JB, "Intravitreal injection of triamcinolone for diffuse diabetic macular edema", 121, pp.57~61 (2003)
- Martidis A, "Intravitreal triamcinolone for refractory diabetic macular edema", 109, pp.920~927 (2002)
- Jonas JB, "Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy", 84, pp.1064~1067 (2000)
- Sakamoto T, "Triamcinolone assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown", 240, pp.423~429 (2002)
- Bresnick GH Diabetic macular edema, "a review", 93, pp.989~97 (1986)
- Stratton IM, "UKPDS 50:risk factors for incidence and progression of retinopathy in typeⅡ diabetes over 6 years from diagnosis", 44, pp.156~163 (2001)
- McDonald HR, "Macular edema following panretinal photocoagulation", 5, pp.5~10 (1985)
- McDonald HR, "Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy", 92, pp.388~93 (1985)
- Higgins KE, "Temporary loss of foveal contrast sensitivity associated with panretinal photocoagulation", 104, pp.997~1003 (1998)
- Gardner TW, "Reduction of severe macular edema in eyes with poor vision after panretinal photocoagulation for proliferative diabetic retinopathy", 229, pp.323~8 (1991)
- Aiello LM, "Diagnosis, management and treatment of nonproliferative diabetic retinopathy and macular edema", 3, pp.138~ (2000), Philadelphia: WB Saunders
- Early Treatment Diabetic Retinopathy Study Research Group, "Early photocoagulation for diabetic retinopathy.ETDRS report number 9", 98, pp.766~86 (1991)
- Jonas JB, "Intraocular pressure after intravitreal injection of triamcinolone acetonide", 87, pp.24~27 (2003)
- Jonas JB, "Secondary chronic open angle glaucoma after intravitreal triamcinolone acetonide", 121, pp.729~730 (2003)
- Moshfeghi DM, "Acute endophthalmitis following intravitreal triamcinolone acetonide injection", 136, pp.791~796 (2003)
- Antoszyk AN, "The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization", 231, pp.34~40 (1993)
- Gillies MC, "A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration:one-year results", 121, pp.667~673 (2003)
- Jonas JB, "Regression of neovascular iris vessel by intravitreal injection of crystalline cortisol", 10, pp.284~287 (2001)
- Wilson CA, "Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation", 110, pp.1155~1159 (1992)
- Zacks DN, "Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy", 25, pp.135~140 (2005)